OPEN Journal of the American College of Cardiology | 5 Nov 2016
TF Brouwer, D Yilmaz, R Lindeboom, MS Buiten, LR Olde Nordkamp, MJ Schalij, AA Wilde, L van Erven and RE Knops
Transvenous implantable cardioverter-defibrillators (TV-ICDs) improve survival in patients at risk for sudden cardiac death, but complications remain an important drawback. The subcutaneous ICD (S-ICD) was developed to overcome lead-related complications. Comparison of clinical outcomes of both device types in previous studies was hampered by dissimilar patient characteristics.
* Data courtesy of Altmetric.com